How severe is CVE-2022-37017?

CVE-2022-37017 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.

Is CVE-2022-37017 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-37017?

CVE-2022-37017 affects Broadcom Symantec Endpoint Protection. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-37017?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-37017 published?

CVE-2022-37017 was published on 2022-12-01 and last updated on 2026-06-17.

CVE-2022-37017

CVE-2022-37017 is a high-severity vulnerability in Broadcom Symantec Endpoint Protection with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: High (CVSS 3.x base score 7.5)
EPSS exploit prediction: 1% (62nd percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Broadcom Symantec Endpoint Protection
Published: 2022-12-01
Last modified: 2026-06-17

Description

Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be susceptible to a Security Control Bypass vulnerability, which is a type of issue that can potentially allow a threat actor to circumvent existing security controls. This CVE applies narrowly to the Client User Interface Password protection and Policy Import/Export Password protection, if it has been enabled.

Frequently asked questions

What is CVE-2022-37017?: Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be susceptible to a Security Control Bypass vulnerability, which is a type of issue that can potentially allow a threat actor to circumvent existing security controls. This CVE applies narrowly to the Client User Interface Password protection and Policy Import/Export Password protection, if it has been enabled.
How severe is CVE-2022-37017?: CVE-2022-37017 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2022-37017 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-37017?: CVE-2022-37017 affects Broadcom Symantec Endpoint Protection. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-37017?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-37017 published?: CVE-2022-37017 was published on 2022-12-01 and last updated on 2026-06-17.

References

https://support.broadcom.com/web/ecx/support-content-notification/-/external/content/SecurityAdvisories/0/21014

Affected products (1)

cpe:2.3:a:broadcom:symantec_endpoint_protection:*:*:*:*:*:windows:*:*

More vulnerabilities in Broadcom Symantec Endpoint Protection

CVE-2022-37016 — Critical (CVSS 9.8): Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation vulnerability, which is a…
CVE-2022-25631 — High (CVSS 7.8): Symantec Endpoint Protection, prior to 14.3 RU6 (14.3.9210.6000), may be susceptible to a Elevation of Privilege…

All CVEs affecting Broadcom Symantec Endpoint Protection →